Price $324.70 |
Market Cap
236.61B
|
Sector Health Care |
Div. Growth
8.70%
|
|
P/E
45.0
|
P/B
6.02
|
P/S
8.89
|
Dividend %
0.30%
|
|
P/CF
136.6
|
P/FCF
39.2
|
Op. Cash Flow
7.94M
|
FCF
8.4
|
|
Op. Margin
25.00%
|
Net Margin
20.40%
|
ROE
14.70%
|
ROI
6.60%
|
|
ROA
7.20%
|
EPS Growth
60.90%
|
Current Ratio
1.9
|
Debt/Equity
58.10%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Capital Senior Living Corporat (CSU) | $31.46 | - | - | 78.9M | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $60.33 | - | 3.00% | 146.93B | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $8.68 | - | - | 10.34B | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.59 | - | - | 30.3M | Strong Buy |
| Cidara Therapeutics Inc (CDTX) | $2.14 | - | - | 107.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
